Clinical Trial Update: Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating add-on sarcosine for efficacy and safety in major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Sarcosine (sarcosine)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED